Atlas Trials

Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?

Clinical trial NCT05217212 · UNKNOWN

Trial details

NCT number
NCT05217212
Sponsor
Luzerner Kantonsspital
Status
UNKNOWN
Study type
OBSERVATIONAL
Head and Neck Squamous Cell Carcinoma
Start date
2020-01-01
Primary completion
2024-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.